The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group

Molecular screening: Multinational testing doable, but technical challenges remain A pilot study demonstrated that a large-scale, international screening programme for women with metastatic breast cancer is feasible. The study, coordinated by the Institut Jules Bordet and the Breast International Gr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marion Maetens, David Brown, Alexandre Irrthum, Philippe Aftimos, Giuseppe Viale, Sibylle Loibl, Jean-François Laes, Peter J. Campbell, Alastair Thompson, Javier Cortes, Sabine Seiler, Sara Vinnicombe, Mafalda Oliveira, Françoise Rothé, Yacine Bareche, Debora Fumagalli, Dimitrios Zardavas, Christine Desmedt, Martine Piccart, Sherene Loi, Christos Sotiriou
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Acceso en línea:https://doaj.org/article/f8462052d39a42d18d1d361021e2031f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f8462052d39a42d18d1d361021e2031f
record_format dspace
spelling oai:doaj.org-article:f8462052d39a42d18d1d361021e2031f2021-12-02T12:30:31ZThe AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group10.1038/s41523-017-0026-62374-4677https://doaj.org/article/f8462052d39a42d18d1d361021e2031f2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41523-017-0026-6https://doaj.org/toc/2374-4677Molecular screening: Multinational testing doable, but technical challenges remain A pilot study demonstrated that a large-scale, international screening programme for women with metastatic breast cancer is feasible. The study, coordinated by the Institut Jules Bordet and the Breast International Group, aimed to determine whether biopsies and blood could be collected from women with metastatic breast cancer across Europe and sent to a central laboratory for targeted gene sequencing. Genetic information was successfully obtained for 26 of the 41 participants, 19 of whom had mutations that could be targeted with a known drug, potentially influencing treatment decision-making. They concluded that genomic testing is logistically ready for international molecular screening in routine clinical settings laying the groundwork for the parent European AURORA molecular screening programme which aims at recruiting 1300 metastatic breast cancer patients. However, technical challenges remain to be addressed to ensure the accuracy and robustness across different sequencing platforms.Marion MaetensDavid BrownAlexandre IrrthumPhilippe AftimosGiuseppe VialeSibylle LoiblJean-François LaesPeter J. CampbellAlastair ThompsonJavier CortesSabine SeilerSara VinnicombeMafalda OliveiraFrançoise RothéYacine BarecheDebora FumagalliDimitrios ZardavasChristine DesmedtMartine PiccartSherene LoiChristos SotiriouNature PortfolioarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Breast Cancer, Vol 3, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Marion Maetens
David Brown
Alexandre Irrthum
Philippe Aftimos
Giuseppe Viale
Sibylle Loibl
Jean-François Laes
Peter J. Campbell
Alastair Thompson
Javier Cortes
Sabine Seiler
Sara Vinnicombe
Mafalda Oliveira
Françoise Rothé
Yacine Bareche
Debora Fumagalli
Dimitrios Zardavas
Christine Desmedt
Martine Piccart
Sherene Loi
Christos Sotiriou
The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
description Molecular screening: Multinational testing doable, but technical challenges remain A pilot study demonstrated that a large-scale, international screening programme for women with metastatic breast cancer is feasible. The study, coordinated by the Institut Jules Bordet and the Breast International Group, aimed to determine whether biopsies and blood could be collected from women with metastatic breast cancer across Europe and sent to a central laboratory for targeted gene sequencing. Genetic information was successfully obtained for 26 of the 41 participants, 19 of whom had mutations that could be targeted with a known drug, potentially influencing treatment decision-making. They concluded that genomic testing is logistically ready for international molecular screening in routine clinical settings laying the groundwork for the parent European AURORA molecular screening programme which aims at recruiting 1300 metastatic breast cancer patients. However, technical challenges remain to be addressed to ensure the accuracy and robustness across different sequencing platforms.
format article
author Marion Maetens
David Brown
Alexandre Irrthum
Philippe Aftimos
Giuseppe Viale
Sibylle Loibl
Jean-François Laes
Peter J. Campbell
Alastair Thompson
Javier Cortes
Sabine Seiler
Sara Vinnicombe
Mafalda Oliveira
Françoise Rothé
Yacine Bareche
Debora Fumagalli
Dimitrios Zardavas
Christine Desmedt
Martine Piccart
Sherene Loi
Christos Sotiriou
author_facet Marion Maetens
David Brown
Alexandre Irrthum
Philippe Aftimos
Giuseppe Viale
Sibylle Loibl
Jean-François Laes
Peter J. Campbell
Alastair Thompson
Javier Cortes
Sabine Seiler
Sara Vinnicombe
Mafalda Oliveira
Françoise Rothé
Yacine Bareche
Debora Fumagalli
Dimitrios Zardavas
Christine Desmedt
Martine Piccart
Sherene Loi
Christos Sotiriou
author_sort Marion Maetens
title The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
title_short The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
title_full The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
title_fullStr The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
title_full_unstemmed The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
title_sort aurora pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/f8462052d39a42d18d1d361021e2031f
work_keys_str_mv AT marionmaetens theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT davidbrown theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT alexandreirrthum theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT philippeaftimos theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT giuseppeviale theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT sibylleloibl theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT jeanfrancoislaes theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT peterjcampbell theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT alastairthompson theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT javiercortes theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT sabineseiler theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT saravinnicombe theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT mafaldaoliveira theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT francoiserothe theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT yacinebareche theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT deborafumagalli theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT dimitrioszardavas theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT christinedesmedt theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT martinepiccart theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT shereneloi theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT christossotiriou theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT marionmaetens aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT davidbrown aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT alexandreirrthum aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT philippeaftimos aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT giuseppeviale aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT sibylleloibl aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT jeanfrancoislaes aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT peterjcampbell aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT alastairthompson aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT javiercortes aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT sabineseiler aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT saravinnicombe aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT mafaldaoliveira aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT francoiserothe aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT yacinebareche aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT deborafumagalli aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT dimitrioszardavas aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT christinedesmedt aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT martinepiccart aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT shereneloi aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
AT christossotiriou aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup
_version_ 1718394373445517312